v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 15,608 $ 16,006 $ 31,488 $ 31,809
General and administrative 141,113 132,848 280,035 291,819
Total operating expenses 156,721 148,854 311,523 323,628
Loss from operations (156,721) (148,854) (311,523) (323,628)
Other income (expense):        
Other income 0 0 0 14,000
Interest income 0 1 0 4
Interest expense on loan payable (2,492) (2,493) (4,959) (4,959)
Non-cash interest expense on convertible notes (18,283) (18,282) (36,365) (36,365)
Total other income (expense), net (20,775) (20,774) (41,324) (27,320)
Loss before provision for income taxes (177,496) (169,628) (352,847) (350,948)
Provision for income taxes 0 2,400 0 2,400
Net loss $ (177,496) $ (172,028) $ (352,847) $ (353,348)
Basic loss per common share $ (0.02) $ (0.02) $ (0.05) $ (0.05)
Diluted loss per common share $ (0.02) $ (0.02) $ (0.05) $ (0.05)
Weighted average number of common shares outstanding - basic 7,236,447 7,236,447 7,236,447 7,236,447
Weighted average number of common shares outstanding - diluted 7,236,447 7,236,447 7,236,447 7,236,447